YU41498B - Proces for obtaining 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)-guinazoline chlorohydrate of an antihypertensive effec - Google Patents

Proces for obtaining 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)-guinazoline chlorohydrate of an antihypertensive effec

Info

Publication number
YU41498B
YU41498B YU58/80A YU5880A YU41498B YU 41498 B YU41498 B YU 41498B YU 58/80 A YU58/80 A YU 58/80A YU 5880 A YU5880 A YU 5880A YU 41498 B YU41498 B YU 41498B
Authority
YU
Yugoslavia
Prior art keywords
guinazoline
chlorohydrate
furoyl
effec
proces
Prior art date
Application number
YU58/80A
Other languages
English (en)
Other versions
YU5880A (en
Inventor
E J Honkanen
A K Pippuri
P J Kairisalo
H Thler
M K Koivisto
S A Tuomi
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Priority to SI8010058A priority Critical patent/SI8010058A8/sl
Publication of YU5880A publication Critical patent/YU5880A/xx
Publication of YU41498B publication Critical patent/YU41498B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
YU58/80A 1979-01-31 1980-01-10 Proces for obtaining 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)-guinazoline chlorohydrate of an antihypertensive effec YU41498B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI8010058A SI8010058A8 (sl) 1979-01-31 1980-01-10 Postopek za prodobivanje 6,7-dimetoksi-4-amino-2-/4-(2-furoil)-piperazinil/-kinazolin klorhidrata z antihipertenzivnim učinkom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan

Publications (2)

Publication Number Publication Date
YU5880A YU5880A (en) 1983-02-28
YU41498B true YU41498B (en) 1987-08-31

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
YU58/80A YU41498B (en) 1979-01-31 1980-01-10 Proces for obtaining 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)-guinazoline chlorohydrate of an antihypertensive effec

Country Status (21)

Country Link
US (1) US4271300A (US08088918-20120103-C00476.png)
JP (1) JPS55104280A (US08088918-20120103-C00476.png)
AT (1) AT374475B (US08088918-20120103-C00476.png)
BE (1) BE881297A (US08088918-20120103-C00476.png)
CA (1) CA1128945A (US08088918-20120103-C00476.png)
CH (1) CH644605A5 (US08088918-20120103-C00476.png)
CS (1) CS214692B2 (US08088918-20120103-C00476.png)
DD (1) DD148952A1 (US08088918-20120103-C00476.png)
DE (1) DE3002553A1 (US08088918-20120103-C00476.png)
DK (1) DK158352C (US08088918-20120103-C00476.png)
FI (1) FI67699C (US08088918-20120103-C00476.png)
FR (1) FR2447920A1 (US08088918-20120103-C00476.png)
GB (1) GB2041932B (US08088918-20120103-C00476.png)
HU (1) HU181016B (US08088918-20120103-C00476.png)
NL (1) NL190701C (US08088918-20120103-C00476.png)
NO (1) NO152298C (US08088918-20120103-C00476.png)
PL (1) PL126994B1 (US08088918-20120103-C00476.png)
SE (1) SE430692B (US08088918-20120103-C00476.png)
SU (1) SU900812A3 (US08088918-20120103-C00476.png)
YU (1) YU41498B (US08088918-20120103-C00476.png)
ZA (1) ZA80501B (US08088918-20120103-C00476.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390015A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv 4-amino-quinazoline compounds
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan

Also Published As

Publication number Publication date
FR2447920B1 (US08088918-20120103-C00476.png) 1982-12-03
NO152298C (no) 1985-09-04
PL126994B1 (en) 1983-09-30
JPS6310955B2 (US08088918-20120103-C00476.png) 1988-03-10
DK42680A (da) 1980-08-01
NL8000289A (nl) 1980-08-04
ATA19580A (de) 1983-09-15
SU900812A3 (ru) 1982-01-23
FI67699C (fi) 1985-05-10
YU5880A (en) 1983-02-28
SE8000777L (sv) 1980-08-01
ZA80501B (en) 1981-02-25
NL190701B (nl) 1994-02-01
FI67699B (fi) 1985-01-31
FI790320A (fi) 1980-08-01
DE3002553C2 (US08088918-20120103-C00476.png) 1988-10-27
DE3002553A1 (de) 1980-08-07
AT374475B (de) 1984-04-25
DK158352B (da) 1990-05-07
CA1128945A (en) 1982-08-03
SE430692B (sv) 1983-12-05
GB2041932B (en) 1982-10-27
NO794279L (no) 1980-08-01
DK158352C (da) 1990-10-08
FR2447920A1 (fr) 1980-08-29
CS214692B2 (en) 1982-05-28
DD148952A1 (de) 1981-06-17
NO152298B (no) 1985-05-28
US4271300A (en) 1981-06-02
HU181016B (en) 1983-05-30
NL190701C (nl) 1994-07-01
JPS55104280A (en) 1980-08-09
PL221684A1 (US08088918-20120103-C00476.png) 1980-10-20
CH644605A5 (de) 1984-08-15
GB2041932A (en) 1980-09-17
BE881297A (fr) 1980-05-16

Similar Documents

Publication Publication Date Title
NO802384L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-diarylthiofener
NO803586L (no) Sammensetning og fremgangsmaate ved stabilisering av fyllinger.
AU3246678A (en) N'(4-(substituted phenethyloxy)-phenyl n-methyl-methoxyurea
PT71404B (en) Process for preparing 2,3-dihydro-2,6,7-trisubstituted-5-acylbenzofurans
YU92080A (en) Process for obtaining 5-substituted pyranones
ES488087A0 (es) Procedimiento de obtencion de composiciones cosmeticas
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
NO156615C (no) Fremgangsmaate ved regulering av lommeslipeapparater.
YU41498B (en) Proces for obtaining 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)-guinazoline chlorohydrate of an antihypertensive effec
HK97084A (en) 2-(3,5-disubstituted-2-hydroxyphenyl)-2h-benzotriazoles and stabilized compositions containing them
SE7804487L (sv) Forfarande for framstellning av papperslim
GB2054590B (en) Preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran
BG35748A3 (en) Method for preparing 2- [4- (2- furoyl)- piperazine- 1- yl]- 4- amino- 6, 7- dimetoxyquinazoline
IE800777L (en) Producing 4-(pyridyl-2-oxy)phenoxy-alkanecarboxylic acid¹derivatives.
RO79704A (ro) Procedeu pentru prepararea 5-mercapto-1,2,3-triazolilor
NO146360C (no) Fremgangsmaate ved fremstilling av 10alfa- og 10beta-methyl-2,9-dioxatricyclo-(4.3.1.03,7)-decaner
IL58661A (en) Process for the preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran
SE435284B (sv) Forfarande for framstellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinoazolin
NO154881C (no) Fremgangsmaate ved fremstilling av 5(6)-thiocyan-benzimidazolderivater.
NO802844L (no) Fremgangsmaate ved fremstilling av 2-oxo-dihydrobenzo-(d)(1,3)-oxaziner
ES494891A0 (es) Procedimiento de preparacion de compuestos 1(2h)-isoquinolo-nicos y similares
AU539248B2 (en) Heterocyclic antidepressants
IT7919894A0 (it) Procedimento per la preparazione di tetraidrofurano.
IL52394A0 (en) The preparation of 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
IT7911794V0 (it) Osteotomo per rinoplastica